Situated activity analysis of elite track and field athletes' use of prohibited performance-enhancing substances

被引:29
|
作者
Hauw, Denis [1 ]
Bilard, Jean [1 ]
机构
[1] Univ Montpellier, Fac Sport Sci, Lab Dynam Human Abil & Hlth Behav, F-34090 Montpellier, France
关键词
Doping; situated cognition; elite performance; career; DRUG-USE; COMPETITION; MODEL;
D O I
10.3109/14659891.2010.545858
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
This study aimed to identify the links between the use of prohibited performance-enhancing substances and the changing characteristics of athletes' activity within the framework of situated action and dynamical investigations. The changes in diverse components of activity (e.g. performance, forms of training, modes of involvement) of 10 elite track and field athletes (5 with 2-year suspensions) were compared. Data were collected by enquiries and structured and self-confrontation interviews. Results showed that during the use of prohibited substances, doping athletes appeared (1) to be closed to all external environmental offers except training and performance, (2) to experience changes in their sporting results and (3) to be experiencing disturbances in their lives. Doping appeared after (4) a specific number of years of sporting activity (i.e. 17 years), (5) a specific path had been followed (i.e. a shorter time spent in "open focus" during the development of activity), (6) 2 years of regular legal substance use, (7) a change in training and (8) a period of personal distress. A signature of doping activity was identified in relation to suffering athletes. Several initial conditions that lead to prohibited substance use were extracted and are utilized for educational programmes.
引用
收藏
页码:183 / 197
页数:15
相关论文
共 50 条
  • [1] Predictors of the Use of Performance-Enhancing Substances by Young Athletes
    Goulet, Claude
    Valois, Pierre
    Buist, Andre
    Cote, Melanie
    CLINICAL JOURNAL OF SPORT MEDICINE, 2010, 20 (04): : 243 - 248
  • [2] A motivational model of performance-enhancing substance use in elite athletes
    Donahue, Eric G.
    Miquelon, Paule
    Vaiois, Pierre
    Goulet, Claude
    Buist, Andre
    Vallerand, Robert J.
    JOURNAL OF SPORT & EXERCISE PSYCHOLOGY, 2006, 28 (04): : 511 - 520
  • [3] A new model for understanding performance-enhancing drug use by elite athletes
    Strelan, P
    Boeckmann, RJ
    JOURNAL OF APPLIED SPORT PSYCHOLOGY, 2003, 15 (02) : 176 - 183
  • [5] Use of Performance-Enhancing Substances
    LaBotz, Michele
    Griesemer, Bernard A.
    PEDIATRICS, 2016, 138 (01)
  • [6] Use of performance-enhancing substances
    Washington, RL
    Bernhardt, DT
    Gomez, J
    Johnson, MD
    Martin, TJ
    Reed, FE
    Small, E
    PEDIATRICS, 2005, 115 (04) : 1103 - 1106
  • [7] Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects
    Heuberger, Jules A. A. C.
    Cohen, Adam F.
    SPORTS MEDICINE, 2019, 49 (04) : 525 - 539
  • [8] Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects
    Jules A. A. C. Heuberger
    Adam F. Cohen
    Sports Medicine, 2019, 49 : 525 - 539
  • [9] Risk Profile of Male College Athletes Who Use Performance-Enhancing Substances
    Buckman, Jennifer F.
    Yusko, David A.
    White, Helene. R.
    Pandina, Robert J.
    JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2009, 70 (06) : 919 - 923
  • [10] Performance-Enhancing Drug Use in Recreational Athletes
    Smith, Tobie
    Fedoruk, Matthew
    Eichner, Amy
    AMERICAN FAMILY PHYSICIAN, 2021, 103 (04) : 203 - 204